Stimulus-secretion coupling in chromaffin cells isolated from bovine adrenal medulla.
Bovine adrenal chromaffin cells were isolated by removal of the cortex and sequential collagenase digestion of the medulla. The catecholamine secretory function of these cells was characterized with respect to acetylcholine stimulation, cation requirements, and cytoskeletal elements. The dose-response curve for stimulated release had its half-maximum value at 10(-5) M acetylcholine, and maximum secretion was on the average 7 times that of control basal secretion. The differential release of epinephrine versus norepinephrine after stimulation with 0.1 mM acetylcholine occurred in proportion to their distribution in the cell suspension. The cholinergic receptors were found to be predominantly nicotinic. The kinetics of catecholamine release were rapid, with significant secretion occurring in less than 60 sec and 85% of maximum secretion within 5 min. A critical requirement for calcium in the extracellular medium was demonstrated, and 80% of maximum secretion was achieved at physiologic calcium concentrations. Stimulation by excess potassium (65 mM KCl) also induced catecholamine secretion which differed from acetylcholine stimulation in being less potent, in having a different dependence on calcium concentration, and in its response to the local anesthetic tetracaine. Tetracaine, which is thought to inhibit membrane cation permeability, was able to block acetylcholine-stimulated but not KCl-stimulated secretion. The microtubule disrupting agent vinblastine was able to block catecholamine release whereas the microfilament disrupter cytochalasin B had little effect. The results show the isolated bovine chromaffin cells to be viable, functioning, and available in large quantity. These cells now provide an excellent system for studying cell surface regulation of hormone and neurotransmitter release.
D000313:Adrenal Medulla / Q000166:cytology* / Q000378:metabolism; D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D002417:Cattle; D002838:Chromaffin System / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D013268:Stimulation, Chemical
D002395:Catecholamines
J Physiol. 1963 Jul;167(2):288-310
16992152
J Pharmacol Exp Ther. 1962 Dec;138:360-75
14013351
J Physiol. 1961 Nov;159:40-57
13887557
Acta Physiol Scand. 1961 Apr;51:348-55
13697529
Acta Physiol Scand Suppl. 1955;33(118):45-56
14398342
J Physiol. 1953 Apr 28;120(1-2):15-9
13062215
J Biol Chem. 1951 Nov;193(1):265-75
14907713
J Physiol. 1976 Dec;263(3):417-39
1018274
J Physiol. 1976 Nov;262(3):743-53
1034699
Biochem Pharmacol. 1977 May 1;26(9):817-23
16614
J Neurochem. 1977 Apr;28(4):687-95
142819
J Physiol. 1967 Jul;191(1):107-21
6050606
J Physiol. 1967 Jan;188(1):107-20
4291730
Mol Pharmacol. 1972 Mar;8(2):264-7
4402005
Endocrinology. 1968 May;82(5):1053-8
4297458
Science. 1975 Oct 10;190(4210):157-9
241121
Biochim Biophys Acta. 1976 Jan 14;421(1):168-75
174736
Br J Pharmacol. 1972 May;45(1):129-32
5041460
Br J Pharmacol. 1968 Nov;34(3):451-74
4882190
Ann N Y Acad Sci. 1975 Jun 30;253:653-69
1096726
J Pharmacol Exp Ther. 1971 Apr;177(1):102-8
5566754